| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.38 | 9e-08 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.37 | 0.02 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.25 | 0.002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.25 | 3e-10 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.24 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.23 | 7e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-09 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-05 |